![Jason Gross](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jason Gross
Teknisk/Vetenskaplig/F&U Direktör på
HLS THERAPEUTICS INC.
Förmögenhet: 148 106 $ per 2026-07-31
Profil
Jason A. Gross is currently Vice President-Scientific Affairs at HLS Therapeutics, Inc., a position held since 2014.
Former roles include Vice President-Scientific & Medical Affairs at Cipher Pharmaceuticals, Inc. from 2012 to 2013, Vice President at Lumira Capital Investment Management, Inc., VP-Scientific & Medical Affairs at IVAX Pharmaceuticals, Inc., VP-Regulatory Affairs & Quality Assurance at Drugabuse Sciences, Inc., and Vice President-Scientific Affairs at HLS Therapeutics, Inc. Education includes a doctorate from the University of Arizona.
Kända innehav i offentliga företag
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
HLS THERAPEUTICS, INC. 0,16 % | 2026-06-26 | 49 700 ( 0,16 % ) | 148 106 $ | 2026-07-31 |
Aktiva positioner av Jason Gross
| Företag | Position | Start |
|---|---|---|
| HLS THERAPEUTICS INC. | Teknisk/Vetenskaplig/F&U Direktör | 2014-06-01 |
Tidigare kända positioner av Jason Gross
| Företag | Position | Slut |
|---|---|---|
Lumira Capital Investment Management, Inc.
 Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Privat kapitalinvesterare | 2006-03-31 |
HLS Therapeutics, Inc. /Old/
 HLS Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides specialty pharmaceutical products | Företagsledare/Principal | - |
IVAX Pharmaceuticals, Inc.
 IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Teknisk/Vetenskaplig/F&U Direktör | - |
Drugabuse Sciences, Inc. | Generell Rådgivare | - |
| CIPHER PHARMACEUTICALS INC. | Teknisk/Vetenskaplig/F&U Direktör | - |
Jason Grosss utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
25
Första gradens relationer
7
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 7 |
|---|---|
Cipher Pharmaceuticals, Inc.
 Cipher Pharmaceuticals, Inc. Pharmaceuticals: OtherHealth Technology Provides laboratory testing and medical imaging services | Health Technology |
Lumira Capital Investment Management, Inc.
Lumira Capital Investment Management, Inc. Investment ManagersFinance LUMIRA invests in revenue stage companies that are both privately held and publically traded companies located in the Canada and the United States. The firm focuses on sectors of therapeutic products and medical devices. It participates in the early stage capital financing. | Finance |
University of Arizona
 University of Arizona Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IVAX Pharmaceuticals, Inc.
IVAX Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets pharmaceutical products | Health Technology |
Drugabuse Sciences, Inc. | |
HLS Therapeutics, Inc. /Old/
HLS Therapeutics, Inc. /Old/ Pharmaceuticals: MajorHealth Technology Provides specialty pharmaceutical products | Health Technology |
HLS Therapeutics, Inc.
 HLS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
